Sharing perspective on what investors should expect from the markets in Q2, with Gordon Charlop, Rosenblatt Securities, Anthony Grisanti, GRZ Energy, and Jeff Kilburg, Treasury Curve.
Sharing perspective on whether investors should take a second look at some of the top performers of Q1, with Mike Murphy, Rosecliff Capital managing partner/CEO.
Lionsgate stock has doubled in the past five months. Will the "Hunger Games" franchise power the stock even higher? Mark Newton, Greywolf Execution Partners, weighs in.
Ryan Detrick, Schaeffer's Investment Research, and Russ Koesterich, BlackRock iShares Group, discuss the trading week, and the market's overall performance in 2012.
The Fast Money traders weigh in on buying protection on long positions and discussing whether the 2012 rally is cooling off, and how to trade a slowdown in global growth. Also, Michael Harris, Campbell & Company, checks the charts on the S&P uptrend and the direction of equities and oil.
Nike reports earnings after the bell today. Should investors get in on the stock now? Barry Sine, Drexel Hamilton, and Paul Swinand, Morningstar, discuss.
If Goldman Sachs is correct on their bold call to buy into equities, where are the buying opportunities? Advice for investors, with Henry Herrmann, Waddell & Reed Financial and Erik Ristuben, Russell Investments.
Insight on why Kevin Sterling, BB&T transportation analyst, has upped his price target on FedEx from $95 to $110 ahead of the shipping company's Q3 earnings release tomorrow.
Looking ahead to 2050, Carl McDonald, Citi health care analyst, shares insight on how cost could change, which companies will benefit, and ways in which Medicare and Medicaid could develop.